scholarly journals INFLUENCE OF INITIAL VOLUME OF CERVICAL CANCER ON ACHIEVING THE RECOMMENDED BRACHYTHERAPY DOSE AT TARGET VOLUMES

Author(s):  
Aleksandar Tomasevic
2020 ◽  
Author(s):  
Aleksandar Tomasevic ◽  
Vesna Plešinac Karapandžić ◽  
Sandra Vučković ◽  
Dragoslava Marjanović ◽  
Mirjana Miković ◽  
...  

2016 ◽  
Vol 57 (6) ◽  
pp. 677-683 ◽  
Author(s):  
Yoshifumi Oku ◽  
Hidetaka Arimura ◽  
Tran Thi Thao Nguyen ◽  
Yoshiyuki Hiraki ◽  
Masahiko Toyota ◽  
...  

Abstract This study investigates whether in-room computed tomography (CT)-based adaptive treatment planning (ATP) is robust against interfractional location variations, namely, interfractional organ motions and/or applicator displacements, in 3D intracavitary brachytherapy (ICBT) for uterine cervical cancer. In ATP, the radiation treatment plans, which have been designed based on planning CT images (and/or MR images) acquired just before the treatments, are adaptively applied for each fraction, taking into account the interfractional location variations. 2D and 3D plans with ATP for 14 patients were simulated for 56 fractions at a prescribed dose of 600 cGy per fraction. The standard deviations (SDs) of location displacements (interfractional location variations) of the target and organs at risk (OARs) with 3D ATP were significantly smaller than those with 2D ATP (P < 0.05). The homogeneity index (HI), conformity index (CI) and tumor control probability (TCP) in 3D ATP were significantly higher for high-risk clinical target volumes than those in 2D ATP. The SDs of the HI, CI, TCP, bladder and rectum D2cc, and the bladder and rectum normal tissue complication probability (NTCP) in 3D ATP were significantly smaller than those in 2D ATP. The results of this study suggest that the interfractional location variations give smaller impacts on the planning evaluation indices in 3D ATP than in 2D ATP. Therefore, the 3D plans with ATP are expected to be robust against interfractional location variations in each treatment fraction.


2017 ◽  
Vol 122 (1) ◽  
pp. 116-121 ◽  
Author(s):  
Gemma Eminowicz ◽  
Vasilis Rompokos ◽  
Christopher Stacey ◽  
Lisa Hall ◽  
Mary McCormack

Author(s):  
L. van de Bunt ◽  
I.M. Jurgenliemk-Schulz ◽  
G. de Kort ◽  
J.M. Roesink ◽  
J.H.A. Tersteeg ◽  
...  

2020 ◽  
Vol 93 (1114) ◽  
pp. 20190564
Author(s):  
Vikneswary Batumalai ◽  
Siobhan Burke ◽  
Dale Roach ◽  
Karen Lim ◽  
Glen Dinsdale ◽  
...  

Objectives: The use of MRI is becoming more prevalent in cervical cancer external beam radiotherapy (RT). The aim of this study was to investigate the impact of dosimetric differences between CT and MRI-derived target volumes for cervical cancer external beam RT. Methods: An automated planning technique for volumetric modulated arc therapy was developed. Two automated planning plans were generated for 18 cervical cancer patients where planning target volumes (PTVs) were generated based on CT or MRI data alone. Dose metrics for planning target volumes and organs at risk (OARs) were compared to analyse any differences based on imaging modality. Results: All treatment plans were clinically acceptable. Bladder doses (V40) were lower in MRI-based plans (p = 0.04, 53.6 ± 17.2 % vs 60.3 ± 13.1 % for MRI vs CT, respectively). The maximum dose for left iliac crest showed lower doses in CT-based plans (p = 0.02, 47.8 ± 0.7 Gy vs 47.4 ± 0.4 Gy MRI vs CT, respectively). No significant differences were seen for other OARs. Conclusions: The dosimetric differences of CT- and MRI-based contouring variability for this study was small. CT remains the standard imaging modality for volume delineation for these patients. Advances in knowledge: This is the first study to evaluate the dosimetric implications of imaging modality on target and OAR doses in cervical cancer external beam RT.


Sign in / Sign up

Export Citation Format

Share Document